I
Ironwood Pharmaceuticals
We are committed to advancing the treatment of GI diseases and redefining the standard of care for GI patients
At a glance
- Status
- Listed
- Listing
- IPO 2010
News
Open roles
Ironwood Pharmaceuticals in the Boston ecosystem
The Ironwood Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later4 investors entered at this stage
Polaris Partners
Morgan Stanley- WIWhitehead Institute
Notable Capital
Source: Dealroom Talent Intelligence.
Alumni founders
Former Ironwood Pharmaceuticals employees who went on to found companies, sorted by Dealroom signal score.
BSBloom ScienceEst. 2018
RMRepertoire Immune MedicinesEst. 2020
Bart HendersonUnited States
VCVets First ChoiceEst. 2010
David E. ShawUnited StatesPatents
52 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Ironwood Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


